Q
QuantAbundanceAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

30,464 signal articles · 149 in last 24h · 154,187 total before filter · latest 1h ago
149last 24h
874last 7d
144● bullish (7d)
96● bearish (7d)
214publishers
AllMacro211Earnings108M&A125Regulatory21Product21Analyst18
✕ clear all filtersticker: JPMSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
From Fashion to Concrete: J.P. Morgan Says Buy These 2 Stocks
TipRanks11d agobullish
From Fashion to Concrete: J.P. Morgan Says Buy These 2 Stocks

Once again, earning season has left market watchers feeling upbeat. Across the S&P 500 index, revenues were up 16% year-over-year, and earnings growth came close to 52%. Profit margins are at or near record highs, and better yet, the gains are broad. Some 86% of reporting companies have beaten earnings expectations, a clear sign of a healthy bull market. While AI, semiconductors, and cloud computing are still powering the bullish trend, the breadth of the market gains means that investors can fi

JPMorgan Says Rising Bond Yields Unlikely to Derail Equities as Earnings Momentum Continues
InvestorsHub12d agoneutral
JPMorgan Says Rising Bond Yields Unlikely to Derail Equities as Earnings Momentum Continues

JPMorgan analysts said higher government borrowing costs and inflation remain risks, but continued corporate earnings growth could support equity markets if inflation expectations remain anchored. Key Investor TakeawaysJPMorgan expects earnings momentum to remain an important support for equities despite rising bond yields and renewed inflation pressures.

Investing.com13d agobearish
JPMorgan cuts off lending to Aschenbrenner’s AI fund after historic losses - FT

Investing.com -- JPMorgan Chase & Co (NYSE:JPM) has terminated its prime brokerage lending relationship with Leopold Aschenbrenner’s hedge fund, Situational Awareness, following record-setting losses linked to a broader downturn in artificial intelligence stocks, according to reporting by the Financial Times. The decision by Wall Street's largest bank cuts off a vital source of leverage for the mid-twenties investor, whose fund suffered the largest dollar loss in hedge fund industry history duri

3 Reasons to Sell JPM and 1 Stock to Buy Instead
StockStory13d agoneutral
3 Reasons to Sell JPM and 1 Stock to Buy Instead

JPMorgan Chase has had an impressive run over the past six months as its shares have beaten the S&P 500 by 10.3%. The stock now trades at $353.72, marking a 23% gain. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.

JPMorgan: Eight Developed-Market Central Banks to Lift Rates Soon
The Wall Street Journal13d agoneutral
JPMorgan: Eight Developed-Market Central Banks to Lift Rates Soon

JPMorgan Chase analysts expect eight of the world's nine developed-market central banks to lift interest rates before the end of the year in efforts to tame sticky inflation and commodity price pressures. In a research note published Thursday, the analysts said they expect rate hikes from the Federal Reserve, Bank of Japan and European Central Bank, as well as from central banks in Australia, New Zealand, the United Kingdom, Norway and Sweden. JPMorgan said its base case was for the Fed to hold rates next week and lift them in December.

Investing.com13d agoneutral
JPMorgan cautious on Hims & Hers on GLP-1 transition risk

Investing.com -- JPMorgan revealed Friday that it has started coverage of Hims & Hers Health at Neutral, setting a December 2027 price target of $32 as it weighs the direct-to-consumer health platform's rapid growth against execution risks in its shift to branded weight-loss drugs.